Breast cancer linked with brain changes, particularly after chemotherapy

The findings of a recent study add to the growing body of evidence of neurologic impairment associated with primary breast cancer. Although these problems can occur irrespective of the patient's treatment history, women who have undergone chemotherapy appear to fare the worst.

The observational study involved 25 women with breast cancer who had received chemotherapy, 19 women with breast cancer who had not received chemotherapy, and 18 healthy female controls, all matched for age and other demographic variables. When the women were asked to perform various tasks, functional MRI showed that those with breast cancer demonstrated significantly reduced activation in the left middle dorsolateral prefrontal cortex and premotor cortex compared with healthy controls.

The subset of cancer patients who had undergone chemotherapy also demonstrated significantly reduced left caudal lateral prefrontal cortex activation and reduced processing speed compared with healthy controls or women with breast cancer who had not received chemotherapy. The findings suggested that the negative effects of chemotherapy on brain function may be exacerbated by such factors as increased age and lower educational level.

“This study provides further evidence that primary breast cancer may cause measurable brain injury,” wrote Shelli R. Kesler, PhD, and co-investigators at Stanford University School of Medicine, Stanford, California, in Archives of Neurology (2011;68[11]:1447-1453). “Women treated with chemotherapy may show additional prefrontal deficits and have difficulty compensating for neurobiological changes such that they also show impaired executive function.”

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs